Notification from Simeon Donev in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD as of 23 July, 2025
Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD
Notification from "Telso" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD
Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma AD
Выручка от продаж за июня 2025 г.
София, Болгария, 21 июля 2025 г. – В соответствии с требованиями ст. 100т из ЗППЦБ, „Софарма“ АД (SFA: Болгарская фондовая биржа, SPH: Варшавская фондовая биржа) сообщает,
что во июня 2025 года Компания зафиксировала рост продаж на 49% по сравнению с тем же месяцем прошлого года, в т.ч. 5% рост продаж на внутреннем рынке и 92% рост экспортных продаж из-за неравномерного восстановления продаж на основных экспортных рынках.
Notification of sale of treasury shares as of 21 July, 2025
Sofia, Bulgaria, July 21, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 18, 2025 the Company sold 81 170 (eighty-one thousand one hundred seventy) repurchased own shares representing 0.05% of the share capital of the Company, at a total value of BGN 203 088.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.50.
Notification of sale of treasury shares as of 18 July, 2025
Sofia, Bulgaria, July 18, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 17, 2025 the Company sold 72 486 (seventy two thousand four hundred eighty-six) repurchased own shares representing 0.04% of the share capital of the Company, at a total value of BGN 185 539.56 on the Bulgarian Stock Exchange, the average price per share was BGN 2.56.
Notification of sale of treasury shares as of 17 July, 2025
Sofia, Bulgaria, July 17, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 16, 2025 the Company sold 1 000 (one thousand) repurchased own shares representing 0.001% of the share capital of the Company, at a total value of BGN 2 580.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.58.
Notification of sale of treasury shares as of 16 July, 2025
Sofia, Bulgaria, July 16, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 15, 2025 the Company sold 344 580 (three hundred forty-four thousand five hundred eighty) repurchased own shares representing 0.19% of the share capital of the Company, at a total value of BGN 898 228.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.61.
Страницы
- « первая
- ‹ предыдущая
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- следующая ›
- последняя »